跳至主要内容
临床试验/NCT06745167
NCT06745167尚未招募不适用

Comparative Efficacy and Safety of Electro-Anatomical Guided Pulsed Field Ablation Versus Radiofrequency Ablation in the Treatment of Persistent Atrial Fibrillation: A Randomized Controlled Trial

Shanghai Chest Hospital1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2025年1月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
入组人数
600
试验地点
1
主要终点
Freedom from Atrial Arrhythmia Recurrence at 12 Months

研究概览

简要总结

This multicenter, randomized controlled trial aims to compare the efficacy and safety of extensive electro-anatomical guided pulsed field ablation (EXT-PFA) with traditional radiofrequency ablation (RF) in treating persistent atrial fibrillation (PeAF). The trial seeks to determine if EXT-PFA, which integrates anatomical and electrogram-guided strategies, can provide superior outcomes in terms of safety and effectiveness compared to the standard RF ablation approach.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •1.Adults aged 18-80 years diagnosed with persistent atrial fibrillation. 2.Ineffectiveness or intolerance to at least one Class I or III anti-arrhythmic drug.

排除标准

  • •Major valvular diseases needing surgical intervention.
  • •Presence of a left atrial thrombus on recent imaging.
  • •Recent myocardial infarction or severe heart failure (LVEF ≤ 30%).
  • •Current Severe Infection.

研究组 & 干预措施

Pulsed field ablation

Experimental

Utilizing pulsed field ablation (PFA), combining pulmonary vein isolation (PVI) with extensive ablation based on anatomical landmarks (including posterior wall box isolation) and electrogram-guided ablation, aiming to target all potential arrhythmic substrates.

干预措施: Pulsed field ablation (Procedure)

Radiofrequency Ablation

Active Comparator

Using conventional radiofrequency ablation technology, combines pulmonary vein isolation (PVI) with extensive ablation based on anatomical landmarks (including posterior wall box isolation) and electrogram-guided ablation, aiming to target all potential arrhythmic substrates.

干预措施: Radiofrequency ablation alone (Procedure)

结局指标

主要结局

Freedom from Atrial Arrhythmia Recurrence at 12 Months

时间窗: 12 months after ablation procedure

Proportion of participants free from atrial fibrillation/atrial flutter/atrial tachycardia recurrence at 12 months post-ablation.

次要结局

  • Procedural Safety(From enrollment to completion of follow-up(at least 12 months))
  • Symptom Relief (EHRA scores)(From enrollment to completion of follow-up(at least 12 months))
  • Quality of Life (Short Form 36 Health Survey).(From enrollment to completion of follow-up(at least 12 months))
  • Atrial Fibrillation Burden Reduction(From enrollment to completion of follow-up(at least 12 months))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xu Liu

MD

Shanghai Chest Hospital

研究点 (1)

Loading locations...

相似试验